Economic evaluation of MR cholangiopancreatography compared to diagnostic ERCP for the investigation of biliary tree obstruction
|
|
- Bennett Francis
- 5 years ago
- Views:
Transcription
1 International Journal of Surgery (2006) 4, 12e19 Economic evaluation of MR cholangiopancreatography compared to diagnostic ERCP for the investigation of biliary tree obstruction Yolanda Bravo Vergel a, *, Jim Chilcott b, Eva Kaltenthaler b, Stephen Walters c, Anthony Blakeborough d, Steven Thomas e a Department of Economics and Related Studies, Centre for Health Economics, University of York, Heslington, York YO10 5DD, UK b ScHARR Technology Assessment Group, School of Health and Related Research, University of Sheffield, S1 4DA, UK c Medical Statistics, School of Health and Related Research, University of Sheffield, S1 4DA, UK d Department of Radiology, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK e Department of Radiology, Northern General Hospital, Sheffield, S5 7AU, UK KEYWORDS Magnetic resonance cholangiopancreatography; Endoscopy; Economic evaluation; Biliary obstruction Abstract Background: Use of magnetic resonance cholangiopancreatography (MRCP) for confirmation of presence of biliary obstruction is virtually risk-free. However, unlike diagnostic endoscopic retrograde cholangiopancreatography (ERCP), no therapeutic option can be offered simultaneously with MRCP. The aim of the study is to assess the cost-effectiveness of MRCP when compared with the conventional practice of diagnostic ERCP for the investigation of biliary obstruction in adults. Methods: Cost-effectiveness analysis from the perspective of the health care provider. Sensitivity analysis includes presentation of a family of cost effectiveness acceptability curves and the impact of different risks of common bile duct stones associated with ultrasound and liver function test results. The main outcome measure is cost per quality adjusted life year (QALY). Results: Baseline results, at 37% probability of common bile duct stones, show that MRCP is the dominant strategy, with expected savings of 149 ( 325 to ÿ 15) and expected QALY gain of (0e0.030) per case. The probability of avoiding unnecessary therapeutic ERCP is 30%. For patients at high risk of common bile duct stones (probability >60%) ERCP is the preferable strategy. * Corresponding author. Tel.: þ44 (0) address: yb3@york.ac.uk (Y. Bravo) /$ - see front matter ª 2006 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved. doi: /j.ijsu
2 Economic evaluation of MRCP compared to diagnostic ERCP 13 Conclusions: ThebaselineestimateisthatMRCPwouldbebothcostsavingand would result in improved quality of life outcomes compared to diagnostic ERCP, but its potential sources of economic benefit are highly dependent on access to, and waiting lists for adequate MRI technology at hospital level. ª 2006 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved. Introduction Use of magnetic resonance cholangiopancreatography (MRCP) for confirmation of presence of biliary obstruction is virtually risk-free and its fixed cost is only about half that of diagnostic endoscopic retrograde cholangiopancreatography (ERCP). However, no therapeutic option can be offered simultaneously with MRCP, unlike ERCP; there is thus a trade off between increased diagnostic costs in patients who ultimately require invasive treatment and cost and health benefits for patients who can avoid an unnecessary invasive diagnostic procedure. In the absence of direct economic evidence on this trade off a model based assessment is required. Our model incorporates the most frequent conditions affecting the biliary tree, such as common bile duct stones (CBDS), benign biliary strictures and peripancreatic cancer. 1 The UK NHS R&D Programme commissioned this assessment of the clinical and cost effectiveness of MRCP compared to the conventional practice of diagnostic ERCP for an adult UK population. A monograph in the Health Technology Assessment series gives further details of methods. 2 Almost all patients with symptoms suspected to be of biliary origin in the UK will be referred for ultrasound (US) either by the general practitioner or specialist. 3 Patients for whom MRCP is contraindicated (i.e. exclusions for MRI, such as claustrophobia and cardiac pacemakers) or ERCP (i.e. previous gastric surgery) are excluded from the scope of the model. Cholangiocarcinoma in the intrahepatic bile duct and primary sclerosing cholangitis (PSC) were both excluded because they are uncommon conditions normally associated with liver treatment. The economic and clinical impact of MRCP or ERCP is highly dependent on the incidence of CBDS in the patient groups being considered. Previous research has estimated the incidence of CBDS within populations demonstrating different US and liver function test (LFT) results. 4 The economic impact of MRCP compared to ERCP within these patient groups together with higher risk groups is explored. Methods A probabilistic economic model was constructed in order to evaluate the relative cost-effectiveness of adopting MRCP scanning compared to diagnostic ERCP for the investigation of biliary obstruction in adults. The primary outcome measure for the economic evaluation was cost per quality adjusted life year (QALY). The decision problem is illustrated in the structure of the decision tree presented in Fig. 1. The structure of this decision analytic model includes the most frequent conditions affecting the biliary tree where MRCP can provide diagnostic information comparable to ERCP. 5e8 The decision tree structure and its underlying assumptions were developed in discussion with a consultant gastroenterologist, two consultant radiologists and a consultant biliary pancreatic surgeon. The model considers the costs from the perspective of the health care provider as it is the most relevant to the decision maker within the context of reorganising NHS resources. The time horizon for the analysis was 12 months, the main reason being that the relief of pain is experienced in the short term after the removal of the stone and that more than three-quarters of patients suffering from pancreatic head lesions die within a year of diagnosis. 9 In order to facilitate the modelling, the following main assumptions have been introduced. For MRCP all patients incur the cost of the MRCP test. Patients with a negative test result incur no additional cost and achieve no gain in utility, with false negative patients maintaining a utility associated with an untreated condition, for example CBDS. All patients with a positive MRCP incur the additional cost and utility decrement of a therapeutic ERCP, with endoscopic stent for malignant strictures and surgery for benign strictures. True positives achieve a gain in utility from appropriate treatment and false positives achieve no utility gain. For diagnostic ERCP the tree follows a similar structure with the associated additional utility decrements and mortality risks. See also Table 1 and the HTA monograph 2 for more details of the assumptions within the model.
3 14 Y. Bravo et al. CBD stone - ERCP MRCP T+ Malignant stricture Benign st.- Surgery Endoscopic stent Resection True-negative T- CBD stone False-negative Malignant stricture Patient with suspected biliary obstruction Benign stricture CBD stone - ERCP T+ Malignant stricture Endoscopic stent Resection Diagnostic ERCP Alive T- Benign st. -Surgery True-negative False-negative CBD stone False-negative Malignant stricture Benign stricture Dead Figure 1 Basic decision tree. Base case values and parameters The parameters used in the model and the sources from which these are derived are shown in Table 2. Estimates of sensitivity and specificity for MRCP and ERCP were based on the clinical effectiveness results reported in Kaltenthaler et al. 2 In line with Table 1 Further specific assumptions Repeated diagnostic ERCP after failed cannulation and repeated MRCP because of pitfalls in interpretation are modelled In most cases therapeutic ERCP is performed with sphincterotomy so the option ERCP without sphincterotomy is not modelled There is some risk associated with diagnostic and therapeutic ERCP, so a healthy patient who is tested or treated with ERCP has a lower outcome than a healthy patient who is not MRCP is generally considered risk-free, so the utility of a healthy patient who is tested with MRCP equals perfect health the assumption that diagnostic ERCP is considered as the gold-standard diagnostic test for biliary tree investigation, we assumed perfect sensitivity and specificity. Only accuracy of diagnostic imaging in patients with CBDS was used in order to allow the modelling: estimates for both CBDS and strictures were not possible to pool statistically. Due to statistically significant heterogeneity between the studies, the median values for the sensitivity and specificity of MRCP were used. Peripancreatic cancer causing bile duct obstruction most commonly occurs at the head of the pancreas, and the chances of resectability are around 10%. The probability that curative resection is appropriate is low with the majority of patients undergoing palliative treatment through endoscopic stent placement. 10 The most common cause of benign biliary stricture is iatrogenic bile trauma during cholecystectomy, 11 and major bile duct injuries usually need surgical reconstruction. 12 The model assumes that surgical reconstruction is the primary treatment for benign extrahepatic strictures.
4 Economic evaluation of MRCP compared to diagnostic ERCP 15 Table 2 Base case probabilities, costs and utility estimates Diagnostic ERCP Mean value SD Model distribution MRCP Mean value SD Source Probabilities True positive test P[Tþ r S] 1 e Fixed; for Systematic review MRCP Beta True negative test P[Tÿ r H] 1 e Fixed; for Systematic review MRCP Beta CDBS 0.37 e Beta HES 2000 Malignant stricture 0.17 e Beta HES 2000 Benign stricture 0.9 e Beta HES 2000 Death after diagnostic ERCP Beta e e Cotton et al Overall complications after Normal e e Cotton et al diagnostic ERCP Resection for malignant strictures 0.10 e Fixed Clinical judgement Endoscopic stent for malignant strictures 0.90 e Fixed Clinical judgement Costs MRI - Medical Gastroenterology a e e Normal NHS Reference Costs 2000/01 CT scan - Medical Normal NHS Reference Costs 2000/01 Gastroenterology a Diagnostic ERCP examination Normal e e NHS Reference Costs 2000/01 bile duct w/o cc Diagnostic ERCP examination Normal e e NHS Reference Costs 2000/01 bile duct with cc Therapeutic ERCP - extraction Normal e e NHS Reference Costs 2000/01 CBDS Surgery malignant neoplasm Normal NHS Reference Costs 2000/01 extrahepatic bile ducts (>69 y or with cc) Memotherm biliary stent (palliative) Bilioplasty balloon catheter Normal Normal Northern General Hospital, Bradford Royal Infirmary Utilities Health-related QoL general 1 e Fixed Convention population MRCP examination e e Fixed 1 e Clinical judgement Chest and back pain relating to CBDS and strictures in extrahepatic bile ducts b Normal Cotton et al Diagnostic ERCP procedure e Beta e e Gregor et al only (w/o cc) c ERCP with cc c Normal Gregor et al Therapeutic ERCP w/o cc c,d 0.95 e Beta Gregor et al. 1996, 21 Bass et al Billiary stricture surgery c Normal Bass et al Extrahepatic malignant stricture Normal Luman et al Post-intervention for extrahepatic malignant stricture Normal Luman et al a Elective procedures, relating to hepato-biliary and pancreatic system HRGs section. b Approximated same discomfort relating to gallblader, according to clinical judgement. c Calculated as utility decrements from perfect health state. d Given that therapeutic ERCP costs are common to both intervention and comparator, complication costs are already included in this estimate.
5 16 Y. Bravo et al. Table 3 Key economic and clinical results Mean 95% CI Lower Upper Key clinical results True negative MRCP (%) (i.e. avoiding unnecessary diagnostic ERCP) True positive MRCP (%) (i.e. necessary therapeutic ERCP) Death under diag. ERCP (%) Key economic results Incremental QALYs Incremental costs ÿ 149 ÿ INB ( 20K per QALY) Cost effectiveness Dominant Dominant MRCP vs. ERCP Probability cost e e saving Probability incremental QALYs positive Probability cost effectiveness over 20K per QALY e e The costs of healthcare resources were estimated using the 2000/2001 NHS Reference Costs, for Elective Inpatients. 13 Complication costs are also shown in Table 2. A computed tomography (CT) scan is always performed before surgery for suspected benign or malignant strictures, so the CT fixed cost is added in both branches. Utility scores for the different health states were obtained from the Harvard CUA database, 14 with the exception of utilities related to biliary tree malignant neoplasms, which required an additional literature search. Whilst, of necessity, utility scores were taken from the international literature, all the health state valuations incorporated in the model used the EQ-5D generic measure. Those utilities reported by clinicians were preferred to those reported by patients because of the peculiarities of MRCP in terms of patient satisfaction: in spite of being a non-invasive procedure MRCP scores lower than expected by clinicians because of noise and claustrophobic related reasons. 2 Since we only considered a 12 months time horizon discounting of costs and outcomes was not carried out. The base case results are reported for a population at 37% risk of CBDS, 17% risk of malignancies and 15% risk of benign strictures, according to Finished Clinical Episode (FCE) records. Probabilities of events are proportions so the beta distribution has been used to estimate the probability of having a CBDS, a malignant stricture or a benign stricture, adding up to 69% risk of having an obstruction. Multivariate sensitivity analysis, using Monte Carlo simulation, is presented for the base case population, together with a range of populations at different risks of CBDS. Results The key clinical and economic results for patients with a baseline 31% likelihood of normal ducts, or 200 Incremental Costs (MRCP- ERCP) Figure 2 Incremental QALY (MRCP - ERCP) Cost Effectiveness Plane for MRCP vs Diagnostic ERCP.
6 Economic evaluation of MRCP compared to diagnostic ERCP 17 minor conditions that might require only expectant management, are shown in Table 3. Costeffectiveness results have been displayed on the cost-effectiveness plane in Fig. 2, this indicates the high probability that MRCP dominates ERCP, that is, MRCP results in an improved quality of life and saves money. The probability of avoiding unnecessary diagnostic ERCP, that is the probability of a true negative MRCP, is estimated at 30%. These patients could avoid the unnecessary risk of complications and death associated with diagnostic ERCP, with an overall expected QALY gain estimated at (95% CI 0.0e0.03). The probability that MRCP is cost saving is estimated at approximately 97%, with an overall expected saving of 149 (95% CI 325 to ÿ 15). From this result, we can infer that the cost savings in terms of avoided complications for healthy patients (i.e. true negatives) can compensate for the added diagnostic costs in those patients who need therapeutic intervention (i.e. true positives). The probability that imaging with MRCP has a cost effectiveness better than 20,000 per QALY is estimated at 99%, with an incremental net benefit (INB) of 364 over diagnostic ERCP. Sensitivity analyses The economic impact of MRCP within different risk groups is explored in Table 4 and the cost effectiveness acceptability curves (CEACs) are presented in Fig. 3. The probability of MRCP being cost-effective decreases as the probability of CBDS increases. At a risk of CBDS of 70%, the probability of MRCP being cost-effective compared to diagnostic ERCP at a threshold of 20,000 per QALY is below 50%, in fact diagnostic ERCP is the dominant strategy with an expected QALY gain of (95% CI ÿ0.005 to 0.016) and estimated cost savings of 81 (95% CI ÿ 96 to 222). At a risk of CBD stones around 60%, MRCP is estimated to be cost neutral when compared with ERCP. Discussion It is remarkable that although ERCP has been assumed to be a true gold standard, with perfect specificity and sensitivity, MRCP is still very likely to be considered economically attractive. The baseline estimate is that MRCP would be both cost saving and result in improved quality of life compared to diagnostic ERCP. Table 4 Key economic and clinical results at different risks of CBDS 9% (95% CI) 21% (95% CI) 32% (95% CI) 37% (95% CI) 50% (95% CI) 70% (95% CI) 56 (48e62) 44 (35e53) 34 (24e43) 30 (20e40) 17 (7e27) 0 (ÿ12e9) Key clinical results True negative MRCP (%) 8(5e13) 20 (13e27) 30 (22e37) 34 (26e42) 46 (38e55) 65 (55e74) True positive MRCP (%) Key economic results Incremental QALYs (0.005e0.039) (0.004e0.036) (0.002e0.032) (0.000e0.030) (ÿ0.001e0.022) (ÿ0.005e0.016) Incremental Costs ÿ 329 (ÿ 535eÿ 121) ÿ 249 (ÿ 422eÿ 75) ÿ 177 (ÿ 337eÿ 14) ÿ 149 (ÿ 325e 15) ÿ 60 (ÿ 233e 94) 81 (ÿ 96e 222) INB ( 20K per QALY) 645 ( 321e 1154) 521 ( 234e 978) 403 ( 156e 828) 364 ( 95e 786) 214 ( 2e 547) ÿ 1 (ÿ 170e 267) ICER Dominant Dominant Dominant Dominant Dominant 20, Probability cost saving According to Everett et al. 4 the risks associated with US and liver function test (LFT) results are: US and LFT normal (9% risk of CBDS); US normal and LFT abnormal (21%); US abnormal and LFT normal (32%); and US and LFT abnormal (37%). The risk of benign and malignant strictures is held constant. CBDS, common biliary duct stone; QALY, quality adjusted life year; INB, incremental net benefit; ICER, incremental cost effectiveness ratio.
7 18 Y. Bravo et al. Prob. E[INB] > ,000 10,000 15,000 20,000 25,000 Threshold (MAICER) Baseline risk (37%) Risk CBDS 50% Risk CBDS 60% Risk CBDS 70% Figure 3 Family of cost effectiveness acceptability curves for MRCP, with four levels of risk of CBDS. Although the perspective of the economic evaluation was the NHS as recommended by the National Institute for Clinical Excellence, 15 a societal perspective would have included an account of patients time and personal costs and loss of production due to treatment and poor health. Due to the fact that there is likely to be little difference in the relative impact of societal valuation between the interventions and health outcomes, with potentially a small bias in favour of the less invasive intervention, MRCP, the results are likely to be robust to a change in perspective. One potentially negative consequence of using MRCP as the initial diagnostic technique in evaluating suspected biliary obstruction is that it may delay therapeutic intervention in cases where this is required. No quantitative evidence was available concerning the potential magnitude of this risk although to a large extent it will be dependent on logistic factors determining the delay between diagnostic and therapeutic procedures. A potential benefit of MRCP not captured in the analysis is the use of the magnetic resonance images for presurgical staging of perampullary cancers and additional information about the state of the pancreaticobiliary duct. 16,17 Quantifying the impact on improved final outcomes is not possible from current data sources. The economic impact of considering repeated diagnostic ERCP after failed cannulation or repeated MRCP, because of pitfalls in interpretation, was examined in an alternative model and these modifications did not affect the main economic results. Only one other economic analysis evaluating MRCP compared to diagnostic ERCP has been identified and this was limited to the management of acute biliary pancreatitis. 18 These results showed that the economics of MRCP in patients with acute biliary pancreatitis were highly dependent on the probability of CBDS. At probabilities of CBDS higher than 58%, ERCP was reported to be the least expensive strategy. Our analysis is consistent with these results. Many of the limitations in the technology assessment relate to the poor design and reporting of comparative studies available, in particular on diagnostic test accuracy compared to final diagnosis and impact on clinical practice. The fact that ERCP is not a perfect gold standard reference test means that the diagnostic accuracy of MRCP may be under or over estimated. The clinical impact of these issues is discussed by Kaltenthaler et al. 2 but this assumption also means that the economics of MRCP may well also be under or over estimated depending on the true accuracy of ERCP. Problems with comparative studies of alternative diagnostic strategies for pancreaticobiliary conditions have also been recently noted elsewhere. 19 Ideally, the decision analytic model would use a ROC curve analysis of sensitivity and specificity to capture interdependence and the impact of variation in implied diagnostic thresholds and would be based upon comparative studies of the interventions measuring their impact on final outcomes. Whilst MRCP might have economic benefits compared with diagnostic ERCP, one potentially constraining factor is the availability of
8 Economic evaluation of MRCP compared to diagnostic ERCP 19 adequate MRI technology at hospital level and length of waiting time. However, ERCP is also subject to variation in operator ability and skill and depends on the availability of skilled radiographers and radiologists to carry out and interpret the imaging. In order to understand the real opportunity costs associated with performing MRCP on a routine basis, studies are needed to assess the relative benefits from access to MRI services, so priorities can be addressed rationally. Acknowledgements Funding for this work was provided by the National Coordinating Centre for Health Technology Assessment. Dr W.E.G. Thomas (Consultant Biliary Pancreatic Surgeon and Clinical Director of Surgery for Sheffield Teaching Hospitals) and Dr Conrad Beckett (Consultant Gastroenterologist, Bradford Royal Infirmary) provided clinical advice. References 1. Brennan ME. Periampullary and pancreatic cancer. In: Blumgart LH, Fong Y, editors. Surgery of the liver and biliary Tract. London: W.B. Saunders; Kaltenthaler E, Bravo Vergel Y, Chilcott J, Thomas S, Blakeborough T, Walters S, et al. A systematic review and economic evaluation of magnetic resonance cholangiopancreatography compared with diagnostic endoscopic retrograde cholangiopancreatography. Health Technology Assessment 2004;8(10). 3. Blackbourne LH, Earnhardt RC, Sistrom CL, Abbitt P, Jones RS. The sensitivity and role of ultrasound in the evaluation of biliary obstruction. The American Surgeon 1994;60(9):683e90 [Review]. 4. Everett SM, Hamlin J, Beckett C, Bzeizi K, Kay C. MRCP e An important investigation in patient at low risk of pancreaticobiliary disease. Endoscopy 2002;34(Suppl. II):A Demartines N, Eisner L, Schnabel K, Fried R, Zuber M, Harder F. Evaluation of magnetic resonance cholangiography in the management of bile duct stones. Archives of Surgery 2000;135(2):148e Lomas DJ, Gimson A. Magnetic resonance cholangiopancreatography. Hospital Medicine (London) 2000;61(6): 395e9 [Review]. 7. Farrell RJ, Noonan N, Mahmud N, Morrin MM, Kelleher D, Keeling PW. Potential impact of magnetic resonance cholangiopancreatography on endoscopic retrograde cholangiopancreatography workload and complication rate in patients referred because of abdominal pain. Endoscopy 2001;33(8):668e Alcaraz MJ, De la Morena EJ, Polo A, Ramos A, De la Cal MA, Gonzalez MA. Comparative study of magnetic resonance cholangiography and direct cholangiography. Revista Espanola de Enfermedades Digestivas 2000; 92(7):427e NHS Executive. Guidance on commissioning cancer services. Improving outcomes in upper gastro-intestinal Cancers. The Manual. London; Luman W, Cull A, Palmer KR. Quality of life in patients stented for malignant biliary obstructions. European Journal of Gastroenterology and Hepatology 1997;9(5): 481e John TG, Greig JD, Carter DC, Garden OJ. Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography. Annals of Surgery 1995;221:156e Allema JH, Reinders ME, van Gulik TM, van Leeuwen DJ, Verbeek PC, de Wit LT, et al. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognosis factors for survival. Surgery 1995;17:247e Department of Health. National schedule of reference costs. London; Harvard CUA database < pdf/preferencescores.pdf> [accessed 15/03/03]. 15. National Institute of Clinical Excellence. Information for national collaborating centres and guidelines for developers. Available at: London; Lopez H, Amthauer H, Hosten N, Ricke J, Bohmig M, Langrehr J. Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography. Radiology 2002;224:31e Freeny PC. Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic carcinoma. Annals of Oncology 1999;10(Suppl. 4):12e Arguedas MR, Dupont AW, Wilcox CM. Where do ERCP, endoscopic ultrasound, magnetic resonance cholangiopancreatography, and intraoperative cholangiography fit in the management of acute biliary pancreatitis? A decision analysis model. American Journal of Gastroenterology 2001; 96(10):2892e Flamm CR, Mark D, Aronson N. Evidence-based review of ERCP: introduction and description of systematic review methods. Gastrointestinal Endoscopy 2002;56(Suppl. 6): S161e Cotton PB, Jowell PS, Baillie J. Spectrum of complications after diagnostic ERCP and effects of comorbidities. Gastrointestinal Endoscopy 1994; Gregor J, Ponich T, Detsky A. Should ERCP be routine after an episode of idiopathic pancreatitis? A cost-utility analysis. Gastrointestinal Endoscopy 1996;44: 118e Bass E, Pitt HA, Lillemoe K. Cost-effectiveness of laparoscopic cholecystectomy versus open cholecystectomy. American Journal of Surgery 1993;165(4):466e71.
Appendix J: Full Health Economics Report
1 Appendix J: Full Health Economics Report 1.1 Contents Appendix J: Full Health Economics Report... 1 1.1 Contents... 1 1. Introduction... 1. Decision Problem... 8 1. Systematic Review of Existing Literature...
More informationTHE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 96, No. 10, by Am. Coll. of Gastroenterology ISSN /01/$20.00
THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 96, No. 10, 2001 2001 by Am. Coll. of Gastroenterology ISSN 0002-9270/01/$20.00 Published by Elsevier Science Inc. PII S0002-9270(01)02807-6 Can Endoscopic
More informationOriginal Policy Date 12:2013
MP 6.01.30 Magnetic Resonance Cholangiopancreatography Medical Policy Section Radiology Is12:2013sue 3:2005 Original Policy Date 12:2013 Last Review Status/Date 12:2013 Return to Medical Policy Index Disclaimer
More informationSurveillance proposal consultation document
Surveillance proposal consultation document 2018 surveillance of Gallstone disease: diagnosis and management (NICE guideline CG188) Proposed surveillance decision We propose to not update the NICE guideline
More informationAppendix A: Summary of evidence from surveillance
Appendix A: Summary of evidence from surveillance 2018 surveillance of Gallstone disease: diagnosis and management (2014) NICE guideline CG188 Summary of evidence from surveillance Studies identified in
More informationCholangiocarcinoma (Bile Duct Cancer)
Cholangiocarcinoma (Bile Duct Cancer) The Bile Duct System (Biliary Tract) A network of bile ducts (tubes) connects the liver and the gallbladder to the small intestine. This network begins in the liver
More informationBiliary tree dilation - and now what?
Biliary tree dilation - and now what? Poster No.: C-1767 Congress: ECR 2012 Type: Educational Exhibit Authors: I. Ferreira, A. B. Ramos, S. Magalhães, M. Certo; Porto/PT Keywords: Pathology, Diagnostic
More informationPictorial review of Benign Biliary tract abnormality on MRCP/MRI Liver with Endoscopic (including splyglass) and Endoscopic Ultrasound correlation
Pictorial review of Benign Biliary tract abnormality on MRCP/MRI Liver with Endoscopic (including splyglass) and Endoscopic Ultrasound correlation Poster No.: C-2617 Congress: ECR 2015 Type: Educational
More informationMagnetic Resonance Cholangiopancreatography (MRCP) in a District General Hospital
Magnetic Resonance Cholangiopancreatography (MRCP) in a District General Hospital Poster No.: C-1790 Congress: ECR 2012 Type: Authors: Scientific Exhibit J. A. Maguire 1, H. Kasem 2, M. Akhtar 2, M. Strauss
More informationA LEADER IN ADVANCED ENDOSCOPY AND HEPATOBILIARY SURGERY
A LEADER IN ADVANCED ENDOSCOPY AND HEPATOBILIARY SURGERY St. Peter s Hospital Advanced Endoscopy & Hepatobiliary Center Welcome The St. Peter s Hospital Advanced Endoscopy & Hepatobiliary Center is a leader
More informationPrimary Sclerosing Cholangitis and Cholestatic liver diseases. Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants
Primary Sclerosing Cholangitis and Cholestatic liver diseases Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants I have nothing to disclose Educational Objectives What is PSC? Understand the cholestatic
More informationA patient with an unusual congenital anomaly of the pancreaticobiliary tree
A patient with an unusual congenital anomaly of the pancreaticobiliary tree Thomas Hocker, HMS IV BIDMC Core Radiology Case Presentation September 17, 2007 Review of Normal Pancreaticobiliary Tract Anatomy
More informationFigure 2: Post-cholecystectomy biliary-like pain
Figure 2: Post-cholecystectomy biliary-like pain 1 patient with recurrent episodes of pain (not daily), in the epigastrium/right upper quadrant, lasting >30 mins, building to a steady level, interrupting
More informationERCP and EUS: What s New and What Should We Do?
ERCP and EUS: What s New and What Should We Do? Rajesh N. Keswani, MD Associate Professor of Medicine Division of Gastroenterology Northwestern University Feinberg School of Medicine EUS/ERCP in 2015 THE
More informationCongenital dilatation of the common bile duct and pancreaticobiliary maljunction clinical implications
Langenbecks Arch Surg (2009) 394:209 213 DOI 10.1007/s00423-008-0330-6 CURRENT CONCEPT IN CLINICAL SURGERY Congenital dilatation of the common bile duct and pancreaticobiliary maljunction clinical implications
More informationPancreatic Cancer in adults:
National Institute for Health and Care Excellence Version 1.0 Pancreatic Cancer in adults: diagnosis and management Appendix K 31 July 2017 Draft for Consultation Developed by the National Guideline Alliance,
More informationThe Endoscopic Management of PSC
The Endoscopic Management of PSC Raj J. Shah, M.D. Associate Professor of Medicine Director, Pancreaticobiliary Endoscopy Services University of Colorado at Denver and the Health Sciences Center Why did
More informationThe authors have declared no conflicts of interest.
Diagnostic Accuracy of Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography Findings in the Postorthotopic Liver Transplant Population Authors: *Ashok Shiani,
More informationSex-related differences in predicting choledocholithiasis using current American Society of Gastrointestinal Endoscopy risk criteria
ORIGINAL ARTICLE Annals of Gastroenterology (2018) 31, 1-6 Sex-related differences in predicting choledocholithiasis using current American Society of Gastrointestinal Endoscopy risk criteria Ankit Chhoda
More informationColangitis Esclerosante Primaria: Manejo Clínico y Endoscópico
Colangitis Esclerosante Primaria: Manejo Clínico y Endoscópico Andrés Cárdenas, MD, MMSc, PhD, AGAF, FAASLD GI / Liver Unit, Hospital Clinic Institut de Malalties Digestives i Metaboliques Associate Professor
More informationThe campaign on laboratory: focus on Gallstone Disease and ERCP
The campaign on laboratory: focus on Gallstone Disease and ERCP Mauro Giuliani, MD, Specialist in Visceral Surgery, Vice Head Physician, Surgical Ward, Ospedale Regionale di Locarno Alberto Fasoli, MD,
More informationGreater Manchester EUR Policy Statement on: Asymptomatic Gallstones GM Ref: GM061 Version: 0.2 (21 November 2018)
Greater Manchester EUR Policy Statement on: Asymptomatic Gallstones GM Ref: GM061 Version: 0.2 (21 November 2018) Commissioning Statement Asymptomatic Gallstones Policy Exclusions (Alternative commissioning
More informationCholangiocarcinoma: Radiologic evaluation and interventions
November 2014 Cholangiocarcinoma: Radiologic evaluation and interventions Colin Nevins, Harvard Medical School Year III Agenda Initial course and work-up Endoscopic retrograde cholangiopancreatography
More informationTogether, putting patients first
The Role of a Gastroenterologist in the Diagnosis and Management of Pancreatic Cancer Sarah Jowett, Consultant Gastroenterologist Bradford Teaching Hospitals Trust Leeds Regional Study Day, 12 September
More informationEndoscopic Retrograde Pancreatography and Laparoscopic Cholecystectomy. TEAM 1 Janix M. De Guzman, MD Presentor
Endoscopic Retrograde Pancreatography and Laparoscopic Cholecystectomy TEAM 1 Janix M. De Guzman, MD Presentor Premise 40F Jaundice Abdominal pain US finding of gallstones with apparently normal common
More informationCase Report Uncommon Mixed Type I and II Choledochal Cyst: An Indonesian Experience
Case Reports in Surgery Volume 2013, Article ID 821032, 4 pages http://dx.doi.org/10.1155/2013/821032 Case Report Uncommon Mixed Type I and II Choledochal Cyst: An Indonesian Experience Fransisca J. Siahaya,
More informationCase Report Heterotopic Pancreas within the Proximal Hepatic Duct, Containing Intraductal Papillary Mucinous Neoplasm
Case Reports in Surgery Volume 2015, Article ID 816960, 4 pages http://dx.doi.org/10.1155/2015/816960 Case Report Heterotopic Pancreas within the Proximal Hepatic Duct, Containing Intraductal Papillary
More informationGeneral Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons
General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons MODULE TITLE: UPPER GI & HPB - HEPATIC, PANCREATIC & BILIARY
More informationHepatobiliary investigations
Hepatobiliary investigations Hepatobiliary Services Information for patients Liver i Stomach Pancreas Gall bladder Introduction You have been referred to the Hepatobiliary Unit. We specialise in procedures
More informationPMB definition guideline for metastatic (including advanced) pancreatic cancer
PMB definition guidelines for metastatic (including advanced) pancreatic cancer 1 P a g e Disclaimer: The metastatic stage pancreatic cancer benefit definition has been developed for the majority of standard
More informationEndoscopic Ultrasonography Clinical Impact. Giancarlo Caletti. Gastroenterologia Università di Bologna. Caletti
Clinical Impact Giancarlo Gastroenterologia Università di Bologna AUSL di Imola,, Castel S. Pietro Terme (BO) 1982 Indications Diagnosis of Submucosal Tumors (SMT) Staging of Neoplasms Evaluation of Pancreato-Biliary
More informationEndoscopic Ultrasonography Assessment for Ampullary and Bile Duct Malignancy
Diagnostic and Therapeutic Endoscopy, Vol. 3, pp. 35-40 Reprints available directly from the publisher Photocopying permitted by license only (C) 1996 OPA (Overseas Publishers Association) Amsterdam B.V.
More informationState of the Art Imaging for Hepatic Malignancy: My Assignment
State of the Art Imaging for Hepatic Malignancy: My Assignment CT vs MR vs MRCP Which one to choose for HCC vs Cholangiocarcinoma What special protocols to use for liver tumors Role of PET and Duplex US
More informationEvidence-based guidelines for diagnosis of common bile duct stones Vanja Giljaca University Hospital Center Rijeka Department of Gastroenterology
Evidencebased guidelines for diagnosis of common bile duct stones Vanja Giljaca University Hospital Center Rijeka Department of Gastroenterology Trusted evidence. Informed decisions. Better health. Outline
More informationResearch Article Safety and Yield of Diagnostic ERCP in Liver Transplant Patients with Abnormal Liver Function Tests
Diagnostic and erapeutic Endoscopy, Article ID 314927, 5 pages http://dx.doi.org/10.1155/2014/314927 Research Article Safety and Yield of Diagnostic ERCP in Liver Transplant Patients with Abnormal Liver
More informationType of intervention Treatment. Economic study type Cost-effectiveness analysis.
Preoperative endoscopic sphincterotomy versus laparoendoscopic rendezvous in patients with gallbladder and bile duct stones Morino M, Baracchi F, Miglietta C, Furlan N, Ragona R, Garbarini A Record Status
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACLF. See Acute-on-chronic liver failure (ACLF) Acute kidney injury (AKI) in ACLF patients, 967 Acute liver failure (ALF), 957 964 causes
More informationROLE OF RADIOLOGY IN INVESTIGATION OF JAUNDICE
ROLE OF RADIOLOGY IN INVESTIGATION OF JAUNDICE Dr. Sohan kumar sah *, Dr. Liu Sibin, Dr. sumendra raj pandey, Dr. Prakashmaan shah, Dr. Gaurishankar pandit, Dr. Suraj kurmi and Dr. Sanjay kumar jaiswal
More informationREFERRAL GUIDELINES: GALLSTONES
REFERRAL GUIDELINES: GALLSTONES Document Purpose To ensure patients with gallstones disease are managed appropriately in primary/ secondary care Oxford Radcliffe Hospital Surgical Department Surgical Registrar
More informationUTILITY OF THREE DIMENSIONAL MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY IN EVALUATION OF BILIARY OBSTRUCTION IN ADULTS
- 842 - UTILITY OF THREE DIMENSIONAL MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY IN EVALUATION OF BILIARY OBSTRUCTION IN ADULTS Moanes M. Enaba MD *Tarek H. ELKammash**MD,, Mansour M. Morsy ***MD * Department
More informationWhat to do and not do before seeking surgical consultation for a patient with suspected pancreatic cancer
What to do and not do before seeking surgical consultation for a patient with suspected pancreatic cancer 9 Th Annual Symposium on Gastrointestinal Cancers, St. Louis University School of Medicine Carlos
More informationThe Use of Pancreatoscopy in the Diagnosis of Intraductal Papillary Mucinous Tumor Lesions of the Pancreas
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:S53 S57 The Use of Pancreatoscopy in the Diagnosis of Intraductal Papillary Mucinous Tumor Lesions of the Pancreas KENJIRO YASUDA, MUNEHIRO SAKATA, MOOSE
More informationPost-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options
Post-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options Poster No.: C-1501 Congress: ECR 2015 Type: Educational Exhibit Authors: A. Hadjivassiliou,
More informationBilirubin levels predict malignancy in patients with obstructive jaundice
DOI:1.1111/j.1477-2574.211.312.x HPB ORIGINAL ARTICLE Bilirubin levels predict malignancy in patients with obstructive jaundice Giuseppe Garcea, Wee Ngu, Christopher P. Neal, Ashley R. Dennison & David
More informationACG Clinical Guideline: Primary Sclerosing Cholangitis
ACG Clinical Guideline: Primary Sclerosing Cholangitis Keith D. Lindor, MD, FACG 1, Kris V. Kowdley, MD, FACG 2, and M. Edwyn Harrison, MD 3 1 College of Health Solutions, Arizona State University, Phoenix,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute variceal bleeding management of, 251 262 balloon tamponade of esophagus in, 257 258 endoscopic therapies in, 255 257. See also Endoscopy,
More informationMaking ERCP Easy: Tips From A Master
Making ERCP Easy: Tips From A Master Raj J. Shah, M.D., FASGE Associate Professor of Medicine University of Colorado School of Medicine Co-Director, Endoscopy Director, Pancreaticobiliary Endoscopy Services
More informationTreatment for cancer of the gall bladder
Treatment for cancer of the gall bladder Hepatobiliary Services Information for Patients Liver i Stomach Pancreas Gall bladder Introduction The aim of this booklet is to help you understand more about
More informationReal-world observational data in costeffectiveness analyses: Herceptin as a case study
Real-world observational data in costeffectiveness analyses: Herceptin as a case study DR BONNY PARKINSON, PROFESSOR ROSALIE VINEY, ASSOCIATE PROFESSOR STEPHEN GOODALL AND PROFESSOR MARION HAAS ISPOR AUSTRALIA
More informationQuality & Safety Committee 17 th August 2017 Agenda item: 6.2
SUMMARY REPORT ABM University Health Board Quality & Safety Committee 17 th August 2017 Agenda item: 6.2 Subject Improvements in the management of gallstone disease Prepared by Approved & presented by:
More informationSetting The study setting was hospital. The economic analysis was carried out in California, USA.
Preoperative versus postoperative endoscopic retrograde cholangiopancreatography in mild to moderate gallstone pancreatitis: a prospective randomized trial Chang L, Lo S, Stabile B E, Lewis R J, Toosie
More informationOriginal article: new surgical approaches to the Klatskin tumour
Alimentary Pharmacology & Therapeutics Original article: new surgical approaches to the Klatskin tumour T. M. VAN GULIK*, S. DINANT*, O. R. C. BUSCH*, E. A. J. RAUWS, H. OBERTOP* & D. J. GOUMA Departments
More informationIntraductal papillary neoplasms in the bile ducts
Intraductal papillary neoplasms in the bile ducts Seok Hwa Youn Myunghee Yoon Dong Hoon Shin Kosin University Gospel Hospital Department of general surgery Hepato-biliary-pancreatic division Introduction
More informationPromoting Innovative Practice
Promoting Innovative Practice Fast-track surgery for pancreatic cancer reduces time to treatment, complications and increases the number of patients undergoing successful surgery 1 Mr Keith Roberts, Consultant
More informationGeneral Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons
General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons MODULE TITLE: UPPER GI & HPB - HEPATIC, PANCREATIC & BILIARY
More informationMedical technologies guidance Published: 1 February 2018 nice.org.uk/guidance/mtg35
Memokath-051 stent for ureteric obstruction Medical technologies guidance Published: 1 February 2018 nice.org.uk/guidance/mtg35 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationEndoscopic Management of Biliary Strictures. Sammy Ho, MD Director of Pancreaticobiliary Services and Endoscopic Ultrasound Montefiore Medical Center
Endoscopic Management of Biliary Strictures Sammy Ho, MD Director of Pancreaticobiliary Services and Endoscopic Ultrasound Montefiore Medical Center Malignant Biliary Strictures Etiologies: Pancreatic
More informationPancreatic Cancer (1 of 5)
i If you need your information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 or send an email to: customercare@ salisbury.nhs.uk You are entitled
More informationApproach to the Biliary Stricture
Approach to the Biliary Stricture ACG Eastern Postgraduate Course Washington DC June 8, 2014 Steven A. Edmundowicz MD FASGE Chief of Endoscopy Division of Gastroenterology Professor of Medicine Disclosures
More informationAccuracy of ASGE criteria for the prediction of choledocholithiasis
1130-0108/2016/108/6/309-314 Revista Española de Enfermedades Digestivas Copyright 2016 Arán Ediciones, S. L. Rev Esp Enferm Dig (Madrid) Vol. 108, N.º 6, pp. 309-314, 2016 ORIGINAL PAPERS Accuracy of
More informationAnatomical and Functional MRI of the Pancreas
Anatomical and Functional MRI of the Pancreas MA Bali, MD, T Metens, PhD Erasme Hospital Free University of Brussels Belgium mbali@ulb.ac.be Introduction The use of MRI to investigate the pancreas has
More informationEvolution of Surgery: Role of the Surgeon in the Molecular and Technology Age. Yuman Fong, MD Memorial Sloan-Kettering Cancer Center Rio 2010
Evolution of Surgery: Role of the Surgeon in the Molecular and Technology Age Yuman Fong, MD Memorial Sloan-Kettering Cancer Center Rio 2010 Molecular mechanisms for cancer Prevention and screening Molecular
More informationEndoscopic retrograde cholangiopancreatography versus intraoperative cholangiography for diagnosis of common bile duct stones (Review)
Endoscopic retrograde cholangiopancreatography versus intraoperative cholangiography for diagnosis of common bile duct stones Gurusamy KS, Giljaca V, Takwoingi Y, Higgie D, Poropat G, Štimac D, Davidson
More informationMR cholangiopancreatography; Predicting imaging findings for differentiation of malignant bile ductal obstruction versus benign lesion
Acta Med Kindai Univ Vol.43, No.1 1-8, 2018 1 MR cholangiopancreatography; Predicting imaging findings for differentiation of malignant bile ductal obstruction versus benign lesion Shojiro Hidaka 1,2,
More informationNavigating the Biliary Tract with CT & MR: An Imaging Approach to Bile Duct Obstruction
Navigating the Biliary Tract with CT & MR: An Imaging Approach to Bile Duct Obstruction Ann S. Fulcher, MD Medical College of Virginia Virginia Commonwealth University Richmond, Virginia Objectives To
More informationLahey Clinic Internal Medicine Residency Program: Curriculum for Gastroenterology
Lahey Clinic Internal Medicine Residency Program: Curriculum for Gastroenterology Faculty representative: David L. Burns, MD, CNSP Resident representative: Tom Castiglione, MD Revision date: March 6, 2006
More informationPredictors of abnormalities on magnetic resonance cholangiopancreatography: is there a role when the biliary tree is normal on previous imaging?
ORIGINAL ARTICLE Annals of Gastroenterology (2019) 32, 1-6 Predictors of abnormalities on magnetic resonance cholangiopancreatography: is there a role when the biliary tree is normal on previous imaging?
More informationManagement of Gallbladder Disease
Management of Gallbladder Disease Steven B. Johnson, MD, FACS, FCCM Professor and Chairman, Department of Surgery Program Director, Phoenix Integrated Surgical Residency University of Arizona College of
More informationCost-effectiveness of endovascular abdominal aortic aneurysm repair Michaels J A, Drury D, Thomas S M
Cost-effectiveness of endovascular abdominal aortic aneurysm repair Michaels J A, Drury D, Thomas S M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion
More informationPersonal Profile. Name: 劉 XX Gender: Female Age: 53-y/o Past history. Hepatitis B carrier
Personal Profile Name: 劉 XX Gender: Female Age: 53-y/o Past history Hepatitis B carrier Chief complaint Fever on and off for 2 days Present illness 94.10.14 Sudden onset of epigastric pain 94.10.15 Fever
More informationSetting The setting was not clear. The economic study was carried out in the USA.
Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis Das P, Ng A K, Earle C C, Mauch P M, Kuntz K M Record Status This is a critical
More informationСтенты «Ella-cs» Уважаемые коллеги! Высылаем очередной выпуск «Issue of ELLA Abstracts»
Уважаемые коллеги! Высылаем очередной выпуск «Issue of ELLA Abstracts» A. Esophageal Stenting and related topics 1 AMJG 2009; 104:1329 1330 Letters to Editor Early Tracheal Stenosis Post Esophageal Stent
More informationTratamiento endoscópico de la CEP. En quien como y cuando?
Tratamiento endoscópico de la CEP. En quien como y cuando? Andrés Cárdenas, MD, MMSc, PhD, AGAF, FAASLD GI / Liver Unit, Hospital Clinic Institut de Malalties Digestives i Metaboliques University of Barcelona
More informationENDOSCOPY IN COMPETITION DIAGNOSTICS. Dr. med. Dirk Hartmann Klinikum Ludwigshafen
Falk Symposium 166 GI Endoscopy Standards and Innovations Mainz, 18. 19. September 2008 ENDOSCOPY IN COMPETITION DIAGNOSTICS Dr. med. Dirk Hartmann Klinikum Ludwigshafen ENDOSCOPY IN COMPETITION Competing
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
Appendix B: Scope NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE Post publication note: The title of this guideline changed during development. This scope was published before the guideline
More informationUpper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012
Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012 Version Control This is a controlled document please destroy all previous versions on receipt
More informationImaging of liver and pancreas
Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma
More informationGall bladder cancer. Information for patients Hepatobiliary
Gall bladder cancer Information for patients Hepatobiliary page 2 of 12 Who will provide my care? You will be cared for by a number of professionals who work together. These professionals will be specialist
More informationLiver and Pancreatic Case discussion
The Royal Marsden Liver and Pancreatic Case discussion Dr Ian Chau Consultant Medical Oncologist The Royal Marsden 77 year old gentleman with 2 months history of vague abdominal ache and clinically finding
More informationPrinciples of ERCP: papilla cannulation, indications/contraindications and risks. Dr. med. Henrik Csaba Horváth PhD
Principles of ERCP: papilla cannulation, indications/contraindications and risks Dr. med. Henrik Csaba Horváth PhD Evolution of ERCP 1968. 1970s ECPG Endoscopic CholangioPancreatoGraphy Japan 1974 Biliary
More information6 th August 2018 Day 1 - Gallbladder & Bile duct Topic
Venue: Sterling Hospital Auditorium, Sterling Hospitals, Gurukul Road Ahmedabad, Gujarat 6 th August 2018 Day 1 - Gallbladder & Bile duct Registration(8:00am-8:15am) Inauguration(8:15am-8:30am) Welcome
More informationSafety of endoscopic retrograde cholangiopancreatography in patients 80 years of age and older
Original paper Safety of endoscopic retrograde cholangiopancreatography in patients 80 years of age and older Baydar Behlül 1, Serin Ayfer 2, Vatansever Sezgin 3, Kandemir Altay 3, Çelik Mustafa 3, Çekiç
More informationFrank Burton Memorial Update on Pancreato-biliary Cancers
Frank Burton Memorial Update on Pancreato-biliary Cancers Diagnosis and management of pancreatic cancer: common dilemmas Moderators: Banke Agarwal, MD Paul Buse, MD Evaluation of patients with obstructive
More informationHealth technology The use of oseltamivir for the treatment of influenza in otherwise healthy children.
Effect of influenza treatment with oseltamivir on health outcome and costs in otherwise healthy children Reisinger K, Greene G, Aultman R, Sander B, Gyldmark M Record Status This is a critical abstract
More informationACCURACY OF MRCP COMPARED WITH ERCP IN THE DIAGNOSIS OF BILE DUCT STONES
ejpmr, 2016,3(8), 27-32 SJIF Impact Factor 3.628 Research Article EUROPEAN JOURNAL OF European PHARMACEUTICAL Journal of Pharmaceutical and Medical Research AND MEDICAL RESEARCH ISSN 2394-3211 www.ejpmr.com
More informationManagement of Patients with Suspected Cholangiocarcinoma CLINICAL GUIDELINES
London Cancer Hepatic Pancreatic and Biliary (HPB) Faculty Management of Patients with Suspected Cholangiocarcinoma CLINICAL GUIDELINES JULY 2014 This operational policy is agreed and accepted by: Designated
More information7/11/2017. We re gonna help a lot of people today. Biliary/Pancreatic Endoscopy. AGS July 1-2, Kenneth M. Sigman, MD
Biliary/Pancreatic Endoscopy AGS July 1-2, 2017 Kenneth M. Sigman, MD We re gonna help a lot of people today 1 2 3 4 Cannulation It all starts with cannulation Double Wire Cannulation Difficult cannulations
More informationAn Introduction to Costeffectiveness
Health Economics: An Introduction to Costeffectiveness Analysis Subhash Pokhrel, PhD Reader in Health Economics Director, Division of Health Sciences Why do we need economic evaluation? 2017 2 Patient
More informationPancreas Case Scenario #1
Pancreas Case Scenario #1 An 85 year old white female presented to her primary care physician with increasing abdominal pain. On 8/19 she had a CT scan of the abdomen and pelvis. This showed a 4.6 cm mass
More informationCLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS
CLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of gallstones pathology in adults. It has been benchmarked against
More informationSURGICAL ULTRASOUND (University Diploma)
SURGICAL ULTRASOUND (University Diploma) Note: the whole course will be delivered in English. Objectives : The purpose of this University Diploma is to teach candidates about the basic principles of ultrasound
More informationERCP complications and challenges in their diagnosis and management.
ERCP complications and challenges in their diagnosis and management. Sandie R Thomson Chair of the Division of Gastroenterology, University of Cape Town ERCP Do I have a good Indication? . Algorithm for
More informationMR CHOLANGIOPANCREATOGRAPHY: PROSPECTIVE COMPARISON OF 3-DIMENSIONAL TURBO SPIN ECHO AND SINGLE-SHOT TURBO SPIN ECHO WITH ERCP
R.C. Chen, K.Y. Lin, J.M. Lii, et al MR CHOLANGIOPANCREATOGRAPHY: PROSPECTIVE COMPARISON OF 3-DIMENSIONAL TURBO SPIN ECHO AND SINGLE-SHOT TURBO SPIN ECHO WITH ERCP Ran-Chou Chen, 1,2 Kuang-Yang Lin, 3
More informationMagnetic resonance cholangiopancreatography (MRCP) is an imaging. technique that is able to non-invasively assess bile and pancreatic ducts,
SECRETIN AUGMENTED MRCP Riccardo MANFREDI, MD, MBA, FESGAR Magnetic resonance cholangiopancreatography (MRCP) is an imaging technique that is able to non-invasively assess bile and pancreatic ducts, in
More informationMRI Abdomen Protocol Pancreas/MRCP with Contrast
MRI Abdomen Protocol Pancreas/MRCP with Contrast Reviewed By: Brett Mollard, MD; Anna Ellermeier, MD Last Reviewed: July 2018 Contact: (866) 761-4200 Standard uses: 1. Characterization of cystic and solid
More informationHealth technology The study compared three strategies for diagnosing and treating obstructive sleep apnoea syndrome (OSAS).
Cost-effectiveness of split-night polysomnography and home studies in the evaluation of obstructive sleep apnea syndrome Deutsch P A, Simmons M S, Wallace J M Record Status This is a critical abstract
More informationCLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 8/27/2011 Radiology Quiz of the Week # 35 Page 1 CLINICAL PRESENTATION AND RADIOLOGY
More informationResearch Article The Diagnostic Accuracy of Linear Endoscopic Ultrasound for Evaluating Symptoms Suggestive of Common Bile Duct Stones
Gastroenterology Research and Practice Volume 2016, Article ID 6957235, 5 pages http://dx.doi.org/10.1155/2016/6957235 Research Article The Diagnostic Accuracy of Linear Endoscopic Ultrasound for Evaluating
More informationAddendum to clinical guideline 131, Colorectal cancer
: National Institute for Health Care Excellence Final Addendum to clinical guideline 131, Colorectal cancer Clinical guideline addendum 131.1 Methods, evidence recommendations December 2014 Final version
More informationIntraoperative staging of GIT cancer using Intraoperative Ultrasound
Intraoperative staging of GIT cancer using Intraoperative Ultrasound Thesis For Fulfillment of MSc Degree In Surgical Oncology By Abdelhalim Salah Abdelhalim Moursi M.B.B.Ch (Cairo University ) Supervisors
More information